Volume 10, Number 5—May 2004
Bartonella Species Isolated from Rodents, Greece
To the Editor: Domestic cats and human body lice have been identified as the vectors of Bartonella henselae and B. quintana, respectively, the primary sources of Bartonella-associated human diseases (1). Bartonella species are zoonotic agents that have been isolated from a wide range of mammals in the United States (2) and Europe (3) and have been associated with human diseases (4,5).
This study investigated the potential for infection from Bartonella species in rodents in northern Greece. The small mammals tested were collected with live traps (6). Two sites were surveyed; the first was Nevrokopi, a small town in the Rhodope Mountains near the Greek-Bulgarian border, and the second site included Pramanta, a small village in the Pindos Mountains, and Matsuki, a small village in northwestern Greece. At Nevrokopi, 57 small mammals were captured during 887 trap nights for a success rate of 6.4%. At Pramanta and Matsuki, 13 small mammals were captured during 400 trap nights for a success rate of 3.3%. The 70 captured mammals comprised seven species of rodents. Apodemus flavicollis was the most commonly captured species (87%). Blood samples from each of the trapped mammals were frozen in liquid nitrogen in the field and subsequently stored at –70ºC before bacteria isolation. Bacteria isolation was performed as previously described (7). One hundred microliters of whole mammalian blood was cultured on heart infusion agar containing 5% rabbit blood (Becton Dickinson, Franklin Lakes, NJ) and incubated in 5% CO2 at 35°C for a minimum of 4 weeks. DNA of the putative Bartonella cultures was extracted by using QIAamp Tissue Kit (Qiagen GmbH, Hilden, Germany). Polymerase chain reaction (PCR) was performed by using two oligonucleotides specific for the citrate synthase (gltA) gene of B. henselae Houston 1, primers BhCS 781.p and BhCS 1137.n. Negative and positive controls (double-distilled H2O and DNA from cultures of B. henselae) were used in each PCR run. Products of the correct size were purified (QIAquick PCR Purification kit, Qiagen GmbH) and sequenced with the same primers, BhCS 781.p and BhCS1137.n., in both directions, with the Cy5/Cy5.5 Dye Primer Cycle Sequencing kit on a Long-Read Tower sequencer (Visible Genetics Inc., Toronto, Canada). Three hundred thirty-eight base-pair sequences of the gltA gene were obtained and compared with sequences of other known Bartonella species in GenBank by using the nucleotide BLAST program (National Center for Biotechnology Information; Available from: www.ncbi.nlm.nih.gov/BLAST/). Isolates identified as Bartonella species were obtained from 21 of the 70 blood cultures. All were isolated from A. flavicollis, and one was isolated from Dryomys nitedula. In addition, all were isolated from the first site (Nevrokopi village), and one was isolated from the second site (Pramanta village).
Within these 21 Bartonella isolates, eight genotypes were found. Among these isolates, one (AY 435102 isolated from A. flavicollis trapped in Pramanta), was identical to ma106up strain, isolated from Microtus agresti (AF391789); another (AY 435103 isolated from A. flavicollis trapped in Nevrokopi), was identical to af82up strain (AF391788), also isolated from A. flavicollis (3). Both strains ma106up (AF391789) and af82up (AF391788) were isolated in central Sweden (3) The rest of Bartonella isolates were from mammals trapped in Nevrokopi village and were divided into three phylogenetic groups. The first group, containing 10 isolates (AY435104-AY 435113, isolated from A. flavicollis) and representing four novel genotypes, was 98% similar to B. taylorii (AF 191502, isolated from A. sylvaticus) gltA gene. The second group, consisting of seven isolates that shared the same genotype (AY 435114-AY435120 isolated from A. flavicollis), was 99% similar to B. birtlesii (AF 204272 isolated from Apodemus spp.). The third group consisted of two isolates that shared the same genotype (AY 435121 isolated from D. nitedula, and AY435122 isolated from A. flavicollis); this group was 97% similar to B. grahamii strain V2 (Z70016 isolated from Neomys fodiens).
This is the first study to identify Bartonella in small mammals in Greece. We found that 31.3% of the examined mammals were infected with Bartonella spp. The prevalence of culture-positive infections differed between the two sites (20/57 versus 1/13), although both are mountain areas with similar environmental and climatic conditions. A high prevalence of Bartonella infection in small mammals also has been described in other countries such as the United States (7) and Sweden (3), where 42.2% and 16.5% of the collected rodents were infected with Bartonella spp., respectively. As indicated in these studies, numerous Bartonella species are found in rodents. A. flavicollis was the most commonly captured species in Sweden (110/236), as well as in Greece (61/70). Identical Bartonella strains were isolated from A. flavicollis and Microtus agresti in both countries. Unlike Sweden, where the most frequent genotype was B. grahamii, in this study no isolate was identical to any Bartonella species known to cause human diseases. However, B. elizabethae was first isolated from a patient with endocarditis, and nothing was known concerning the organism’s natural history until it was isolated from a rodent captured in Peru (4).
The occurrence and distribution of Bartonella in European hosts are largely unknown. Given the existence of Bartonella spp. in every mammal group examined to date, the diversity of the genus is probably much greater than has been observed among the strains examined to date. In Greece, serologic evidence of human infection with B. henselae and B. quintana (8), has been found and a case of B. quintana endocarditis has been established (unpub. data). The public health relevance of Bartonella infections in small mammals in Greece compared with other countries remains to be defined.
- Karem KL, Paddock CD, Regnery RL. Bartonella henselae, Bartonella quintana and Bartonella bacilliformis: historical pathogens of emerging significance. Microbes Infect. 2000;2:1193–205.
- Ellis BA, Regnery RL, Beati L, Bacellar F, Rood M, Glass G, Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis. 1999;180:220–4.
- Holmberg M, Mills JN, McGill S, Benjamin G, Ellis BA. Bartonella infection in sylvatic small mammals of central Sweden. Epidemiol Infect. 2003;130:149–57.
- Birtles RJ, Raoult D. Comparison of partial citrate synthase gene (gltA) sequences for phylogenetic analysis of Bartonella species. Int J Syst Bacteriol. 1996;46:891–7.
- Kerkhoff FT, Bergmans AMC, van der Zee A, Rothova A. Demonstration of Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis. J Clin Microbiol. 1999;37:4034–8.
- Papa A, Mills JN, Kouidou S, Ma B, Papadimitriou E, Antoniadis A. Preliminary characterization and natural history of Hantaviruses in rodents in northern Greece. Emerg Infect Dis. 2000;6:654–5.
- Kosoy MY, Regnery RL, Tzianabos T, Marson EL, Jones DC, Green D, Distribution, diversity, and host specificity of Bartonella in rodents from the southeastern United States. Am J Trop Med Hyg. 1997;57:578–88.
- Tea A, Alexiou-Daniel S, Arvanitidou M, Diza E, Antoniadis A. Occurrence of Bartonella henselae and Bartonella quintana in a healthy Greek population. Am J Trop Med Hyg. 2003;68:554–6.
Suggested citation for this article: Tea A, Alexiou-Daniel S, Papoutsi A, Papa A, Antoniadis A. Bartonella species isolated from rodents, Greece. Emerg Infect Dis [serial online]. 2004 May [date cited]. Available from: http://wwwnc.cdc.gov/eid/article/10/5/03-0430
Please use the form below to submit correspondence to the authors or contact them at the following address:
Stella Alexiou-Daniel, Department of Microbiology, AHEPA University Hospital, Thessaloniki 54006, Greece; fax: +32310994821
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: February 22, 2011
- Page last updated: February 22, 2011
- Page last reviewed: February 22, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)